Gavin Halbert

Default user avatar

University of Strathclyde
Robertson Trust wing
161 Cathedral Street
Glasgow
G4 0RE
United Kingdom

Email: formulation.unit@strath.ac.uk
Tel: 0141 548 2454 - office
Web: Lab website

About Gavin Halbert

Professor Gavin Halbert heads up Cancer Research UK's cutting-edge Strathclyde Formulation Unit in Glasgow. At this facility, the scientists package up promising new candidate drugs into safe forms that patients can take as tablets, capsules or injections. 

Recent publications


A phase I study of the nitroimidazole hypoxia marker SR4554 using F-19 magnetic resonance spectroscopy

Br J Cancer.2009;101 :1860-1868

The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study

Ann Oncol.2007;18 :1098-1103